![](/img/cover-not-exists.png)
Extended letermovir administration, beyond day 100, is effective for CMV prophylaxis in patients with graft versus host disease
Bansal, Rajat, Gordillo, Christian A, Abramova, Rachel, Assal, Amer, Mapara, Markus Y, Pereira, Marcus R, Reshef, RanJournal:
Transplant Infectious Disease
DOI:
10.1111/tid.13487
Date:
October, 2020
File:
PDF, 5.15 MB
2020